Literature DB >> 32181113

Enhanced production of lipstatin from mutant of Streptomyces toxytricini and fed-batch strategies under submerged fermentation.

Punit Kumar1, Archana Tripathi2, Umesh Luthra3, Kashyap Kumar Dubey4.   

Abstract

Streptomyces toxytricini produces bioactive metabolite recognized as lipstatin and its intermediate orlistat. The main focus of this study is to enhance lipstatin production by strain improvement and precursor feeding. In this study, strain improvement to enhance the production of lipstatin was carried out by different doses (50, 100, 150, 200, and 250 Gy) of gamma radiation and precursors (Linoleic acid, Oleic acid, and l-Leucine). Screening showed that the highest yield of lipstatin (4.58 mg/g) was produced by mutant designated as SRN 7. The production of lipstatin (5.011 mg/g) increased significantly when the medium was supplemented with ratio 1:1.5 (linoleic acid + oleic acid). The addition of 1.5% l-Leucine leads to further increment in the production of lipstatin (5.765 mg/g). The addition of 10% soy flour in the culture medium resulted in the maximum production of lipstatin to 5.886 mg/g. © King Abdulaziz City for Science and Technology 2020.

Entities:  

Keywords:  Antiobesity drug; Fatty acid precursors; Gamma radiation; Lipstatin; Precursors

Year:  2020        PMID: 32181113      PMCID: PMC7054507          DOI: 10.1007/s13205-020-2147-0

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  20 in total

Review 1.  Improvement of microbial strains and fermentation processes.

Authors:  S Parekh; V A Vinci; R J Strobel
Journal:  Appl Microbiol Biotechnol       Date:  2000-09       Impact factor: 4.813

Review 2.  Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering.

Authors:  Carlos Olano; Felipe Lombó; Carmen Méndez; José A Salas
Journal:  Metab Eng       Date:  2008-07-15       Impact factor: 9.783

3.  Changes in DNA base sequence induced by gamma-ray mutagenesis of lambda phage and prophage.

Authors:  K R Tindall; J Stein; F Hutchinson
Journal:  Genetics       Date:  1988-04       Impact factor: 4.562

4.  Implication of mutagenesis and precursor supplementation towards the enhancement of lipstatin (an antiobesity agent) biosynthesis through submerged fermentation using Streptomyces toxytricini.

Authors:  Punit Kumar; Kashyap Kumar Dubey
Journal:  3 Biotech       Date:  2017-12-26       Impact factor: 2.406

5.  Modulation of fatty acid metabolism and tricarboxylic acid cycle to enhance the lipstatin production through medium engineering in Streptomyces toxytricini.

Authors:  Punit Kumar; Kashyap Kumar Dubey
Journal:  Bioresour Technol       Date:  2016-02-11       Impact factor: 9.642

6.  Biosynthesis of lipstatin. Incorporation of multiply deuterium-labeled (5Z,8Z)-tetradeca-5,8-dienoic acid and octanoic acid.

Authors:  M Goese; W Eisenreich; E Kupfer; P Stohler; W Weber; H G Leuenberger; A Bacher
Journal:  J Org Chem       Date:  2001-06-29       Impact factor: 4.354

7.  Tracer studies with crude U-13C-lipid mixtures. Biosynthesis of the lipase inhibitor lipstatin.

Authors:  W Eisenreich; E Kupfer; W Weber; A Bacher
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

Review 8.  Abdominal obesity and metabolic syndrome.

Authors:  Jean-Pierre Després; Isabelle Lemieux
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

9.  Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity.

Authors:  E K Weibel; P Hadvary; E Hochuli; E Kupfer; H Lengsfeld
Journal:  J Antibiot (Tokyo)       Date:  1987-08       Impact factor: 2.649

10.  Comparative toxicity of oleic acid and linoleic acid on Jurkat cells.

Authors:  Maria Fernanda Cury-Boaventura; Celine Pompéia; Rui Curi
Journal:  Clin Nutr       Date:  2004-08       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.